$EW
Edwards Lifesciences Corp Stock $ew

$ew Overview Financials Valuation SEC Filings Company Website

2021 Form 10-K Financial Statement

#000109980022000005 Filed on February 14, 2022

Income Statement

Concept	2021	2020 Q4	2020
Revenue	$5.233B	$1.192B	$4.386B
YoY Change	19.29%	1.5%	0.88%
Cost Of Revenue	$1.249B	$296.3M	$1.081B
YoY Change	15.57%	3.53%	-3.03%
Gross Profit	$3.984B	$895.4M	$3.306B
YoY Change	20.51%	0.84%	2.23%
Gross Profit Margin	76.13%	75.14%	75.36%
Selling, General & Admin	$1.494B	$338.5M	$1.228B
YoY Change	21.6%	-2.51%	-1.11%
% of Gross Profit	37.5%	37.8%	37.16%
Research & Development	$903.1M	$195.7M	$760.7M
YoY Change	18.72%	0.93%	1.06%
% of Gross Profit	22.67%	21.86%	23.01%
Depreciation & Amortization	$134.8M	$32.60M	$107.2M
YoY Change	25.75%	36.4%	20.04%
% of Gross Profit	3.38%	3.64%	3.24%
Operating Expenses	$2.397B	$539.4M	$1.989B
YoY Change	20.5%	3.21%	-0.29%
Operating Profit	$1.690B	$356.0M	$897.6M
YoY Change	88.31%	-2.55%	-21.73%
Interest Expense	$18.40M	$5.000M	$15.80M
YoY Change	16.46%	-28.57%	-23.67%
% of Operating Profit	1.09%	1.4%	1.76%
Other Income/Expense, Net	$12.70M	-$300.0K	$11.50M
YoY Change	10.43%	0.0%	40.24%
Pretax Income	$1.702B	$356.1M	$916.7M
YoY Change	85.67%	12.87%	-21.41%
Income Tax	$198.9M	$46.60M	$93.30M
% Of Pretax Income	11.69%	13.09%	10.18%
Net Earnings	$1.503B	$309.5M	$823.4M
YoY Change	82.55%	10.46%	-21.35%
Net Earnings / Revenue	28.73%	25.97%	18.77%
Basic Earnings Per Share	$2.41	$0.50	$1.32
Diluted Earnings Per Share	$2.38	$0.49	$1.30
COMMON SHARES
Basic Shares Outstanding	623.3M shares	623.2M shares	622.6M shares
Diluted Shares Outstanding	631.2M shares		631.9M shares

Balance Sheet

Concept	2021	2020 Q4	2020
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.467B	$1.403B	$1.403B
YoY Change	4.58%	-7.54%	-7.54%
Cash & Equivalents	$862.8M	$1.183B	$1.183B
Short-Term Investments	$604.0M	$219.4M	$219.4M
Other Short-Term Assets	$322.3M	$208.2M	$283.3M
YoY Change	13.77%	23.93%	24.75%
Inventory	$726.7M	$802.3M	$802.3M
Prepaid Expenses		$75.10M
Receivables	$582.2M	$514.6M	$514.6M
Other Receivables	$82.70M	$88.20M	$88.20M
Total Short-Term Assets	$3.181B	$3.091B	$3.091B
YoY Change	2.9%	3.59%	3.59%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.639B	$1.395B	$1.489B
YoY Change	10.02%	31.59%	30.6%
Goodwill		$1.173B
YoY Change		0.47%
Intangibles		$331.4M
YoY Change		-1.52%
Long-Term Investments	$1.834B	$5.700M	$801.6M
YoY Change	128.82%	-8.06%	36.91%
Other Assets	$357.5M	$119.6M	$350.5M
YoY Change	2.0%	17.49%	27.92%
Total Long-Term Assets	$5.322B	$4.146B	$4.146B
YoY Change	28.36%	18.32%	18.32%
TOTAL ASSETS
Total Short-Term Assets	$3.181B	$3.091B	$3.091B
Total Long-Term Assets	$5.322B	$4.146B	$4.146B
Total Assets	$8.503B	$7.237B	$7.237B
YoY Change	17.49%	11.54%	11.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$204.5M	$196.5M	$196.5M
YoY Change	4.07%	8.92%	8.92%
Accrued Expenses	$714.2M	$578.7M	$578.7M
YoY Change	23.41%	-9.96%	-9.96%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00	$0.00
YoY Change
Total Short-Term Liabilities	$1.032B	$893.9M	$893.9M
YoY Change	15.48%	-0.94%	-0.94%
LONG-TERM LIABILITIES
Long-Term Debt	$595.7M	$595.0M	$595.0M
YoY Change	0.12%	0.1%	0.1%
Other Long-Term Liabilities	$779.7M	$252.4M	$959.5M
YoY Change	-18.74%	24.15%	42.93%
Total Long-Term Liabilities	$1.375B	$847.4M	$1.555B
YoY Change	-11.52%	6.23%	22.82%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.032B	$893.9M	$893.9M
Total Long-Term Liabilities	$1.375B	$847.4M	$1.555B
Total Liabilities	$2.667B	$2.663B	$2.663B
YoY Change	0.15%	56.63%	13.8%
SHAREHOLDERS EQUITY
Retained Earnings		$4.565B
YoY Change		22.01%
Common Stock		$2.075B
YoY Change		12.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$1.904B
YoY Change		48.91%
Treasury Stock Shares		12.10M shares
Shareholders Equity	$5.836B	$4.574B	$4.574B
YoY Change
Total Liabilities & Shareholders Equity	$8.503B	$7.237B	$7.237B
YoY Change	17.49%	11.54%	11.54%

Cashflow Statement

Concept	2021	2020 Q4	2020
OPERATING ACTIVITIES
Net Income	$1.503B	$309.5M	$823.4M
YoY Change	82.55%	10.46%	-21.35%
Depreciation, Depletion And Amortization	$134.8M	$32.60M	$107.2M
YoY Change	25.75%	36.4%	20.04%
Cash From Operating Activities	$1.732B	$400.0M	$1.054B
YoY Change	64.29%	0.15%	-10.87%
INVESTING ACTIVITIES
Capital Expenditures	$325.8M	-$113.5M	$407.0M
YoY Change	-19.95%	58.74%	59.98%
Acquisitions
YoY Change
Other Investing Activities	$44.40M	-$146.4M	$12.10M
YoY Change	266.94%	-60.83%	9.01%
Cash From Investing Activities	-$1.723B	-$259.9M	-$531.1M
YoY Change	224.33%	-41.63%	-10.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$512.8M		$625.4M
YoY Change	-18.0%		137.52%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$356.3M	41.40M	-$486.9M
YoY Change	-26.82%	11.89%	321.19%
NET CHANGE
Cash From Operating Activities	$1.732B	400.0M	$1.054B
Cash From Investing Activities	-$1.723B	-259.9M	-$531.1M
Cash From Financing Activities	-$356.3M	41.40M	-$486.9M
Net Change In Cash	-$332.8M	181.5M	$15.80M
YoY Change	-2206.33%	-2139.33%	-96.63%
FREE CASH FLOW
Cash From Operating Activities	$1.732B	$400.0M	$1.054B
Capital Expenditures	$325.8M	-$113.5M	$407.0M
Free Cash Flow	$1.406B	$513.5M	$647.3M
YoY Change	117.26%	9.05%	-30.29%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001099800
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	One Edwards Way
CY2021	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	1-15525
CY2021	dei	Entity Registrant Name EntityRegistrantName	EDWARDS LIFESCIENCES CORPORATION
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	36-4316614
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Irvine
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92614
CY2021	dei	City Area Code CityAreaCode	949
CY2021	dei	Local Phone Number LocalPhoneNumber	250-2500
CY2021	dei	Security12b Title Security12bTitle	Common Stock, par value $1.00 per share
CY2021	dei	Trading Symbol TradingSymbol	EW
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	9300000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	9600000	USD
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	64028235982	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	623207437	shares
CY2021	dei	Auditor Firm AuditorFirmId	238
CY2021	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2021	dei	Auditor Location AuditorLocation	Irvine, California
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	862800000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1183200000	USD
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	604000000.0	USD
CY2020Q4	us-gaap	Short Term Investments ShortTermInvestments	219400000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	582200000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	514600000	USD
CY2021Q4	us-gaap	Other Receivables OtherReceivables	82700000	USD
CY2020Q4	us-gaap	Other Receivables OtherReceivables	88200000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	726700000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	802300000	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	85200000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	75100000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	237100000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	208200000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	3180700000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	3091000000	USD
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	1834200000	USD
CY2020Q4	us-gaap	Long Term Investments LongTermInvestments	801600000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1546600000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1395200000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	92100000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	94200000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	1167900000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	1173200000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	323600000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	331400000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	246700000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	230900000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	110800000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	119600000	USD
CY2021Q4	us-gaap	Assets Assets	8502600000	USD
CY2020Q4	us-gaap	Assets Assets	7237100000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	204500000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	196500000	USD
CY2021Q4	ew	Accrued And Other Liabilities Current AccruedAndOtherLiabilitiesCurrent	802300000	USD
CY2020Q4	ew	Accrued And Other Liabilities Current AccruedAndOtherLiabilitiesCurrent	670200000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	25500000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	27200000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1032300000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	893900000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	595700000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	595000000.0	USD
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	62000000.0	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	186100000	USD
CY2021Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	190000000.0	USD
CY2020Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	215300000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	69100000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	72700000	USD
CY2021Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	259000000.0	USD
CY2020Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	214400000	USD
CY2021Q4	us-gaap	Litigation Reserve Noncurrent LitigationReserveNoncurrent	191300000	USD
CY2020Q4	us-gaap	Litigation Reserve Noncurrent LitigationReserveNoncurrent	233000000.0	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	267300000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	252400000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	2666700000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	2662800000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000.0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000.0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1050000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1050000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	642000000.0	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	636400000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	624100000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	624300000	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	642000000.0	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	636400000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1700400000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1438100000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6068100000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4565000000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-157700000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-161100000	USD
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	17900000	shares
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	12100000	shares
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2416900000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1904100000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	5835900000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	4574300000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8502600000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7237100000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5232500000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4386300000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4348000000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1248900000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1080600000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1114400000	USD
CY2021	us-gaap	Gross Profit GrossProfit	3983600000	USD
CY2020	us-gaap	Gross Profit GrossProfit	3305700000	USD
CY2019	us-gaap	Gross Profit GrossProfit	3233600000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1493700000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1228400000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1242200000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	903100000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	760700000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	752700000	USD
CY2021	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	20600000	USD
CY2020	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	405400000	USD
CY2019	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	33400000	USD
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-124100000	USD
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	13600000	USD
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-6100000	USD
CY2021	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	0	USD
CY2020	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	0	USD
CY2019	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	64600000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	1690300000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	897600000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	1146800000	USD
CY2021	us-gaap	Interest Expense InterestExpense	18400000	USD
CY2020	us-gaap	Interest Expense InterestExpense	15800000	USD
CY2019	us-gaap	Interest Expense InterestExpense	20700000	USD
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	17400000	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	23400000	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	32200000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	12700000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	11500000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8200000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1702000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	916700000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1166500000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	198900000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	93300000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	119600000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1503100000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	823400000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1046900000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.41
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.32
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.68
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.38
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.30
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.64
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	623300000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	622600000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	624800000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	631200000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	631900000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	636700000	shares
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1503100000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	823400000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1046900000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-50100000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	32400000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-11200000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	57400000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-40200000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-11100000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-11600000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	4200000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	1900000	USD
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-24100000	USD
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	6600000	USD
CY2019	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	6300000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1503100000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	823400000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1046900000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	134800000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-8600000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-300000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-400000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3400000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-5100000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-17500000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1506500000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	818300000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1029400000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	107200000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	89300000	USD
CY2021	ew	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	28500000	USD
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2019	us-gaap	Inventory Write Down InventoryWriteDown	73100000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-84500000	USD
CY2020	ew	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	28200000	USD
CY2019	ew	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	25300000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	109300000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	92600000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	81300000	USD
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2021	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2020	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2019	us-gaap	Impairment Of Investments ImpairmentOfInvestments	40600000	USD
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-124100000	USD
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	13600000	USD
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-6100000	USD
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	41400000	USD
CY2020	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	49400000	USD
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	2800000	USD
CY2021	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	91100000	USD
CY2020	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-41900000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	195200000	USD
CY2019	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-12100000	USD
CY2021	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	0	USD
CY2020	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	0	USD
CY2019	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	24000000.0	USD
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	23400000	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	3500000	USD
CY2019	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	88000000.0	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-19000000.0	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	120600000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	105400000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-7900000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	28500000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6800000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1182900000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	325800000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	116500000	USD
CY2021	ew	Increase Decrease In Legal Settlement Accrual IncreaseDecreaseInLegalSettlementAccrual	-29200000	USD
CY2020	ew	Increase Decrease In Legal Settlement Accrual IncreaseDecreaseInLegalSettlementAccrual	270500000	USD
CY2019	ew	Increase Decrease In Legal Settlement Accrual IncreaseDecreaseInLegalSettlementAccrual	-180000000.0	USD
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	62000000.0	USD
CY2020	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-52900000	USD
CY2019	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	43200000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	18500000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-16300000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-19700000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1732100000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1054300000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	407000000.0	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	254400000	USD
CY2021	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	250000000.0	USD
CY2020	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	162000000.0	USD
CY2019	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	130200000	USD
CY2021	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	138000000.0	USD
CY2020	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	212200000	USD
CY2019	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	50000000.0	USD
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	1629300000	USD
CY2020	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	689700000	USD
CY2019	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	437900000	USD
CY2021	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	391200000	USD
CY2020	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	564800000	USD
CY2019	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	359900000	USD
CY2021	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	USD
CY2020	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	USD
CY2019	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	100200000	USD
CY2021	us-gaap	Other Payments To Acquire Businesses OtherPaymentsToAcquireBusinesses	13100000	USD
CY2020	us-gaap	Other Payments To Acquire Businesses OtherPaymentsToAcquireBusinesses	10000000.0	USD
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	5200000	USD
CY2019	us-gaap	Other Payments To Acquire Businesses OtherPaymentsToAcquireBusinesses	35000000.0	USD
CY2021	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	5100000	USD
CY2020	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	27000000.0	USD
CY2019	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	12900000	USD
CY2021	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	20000000.0	USD
CY2020	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	USD
CY2019	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	USD
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	4000000.0	USD
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	300000	USD
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	24000000.0	USD
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	44400000	USD
CY2020	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	12100000	USD
CY2019	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	11100000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1722500000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-531100000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-595800000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3000000.0	USD
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	16200000	USD
CY2019	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	18900000	USD
CY2021	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	7000000.0	USD
CY2020	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	140500000	USD
CY2019	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	160500000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-356300000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-486900000	USD
CY2020	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	17000000.0	USD
CY2019	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	28900000	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	512800000	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	625400000	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	263300000	USD
CY2021	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	158600000	USD
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-300000	USD
CY2020	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1200000	USD
CY2019	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-2800000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-115600000	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13900000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-20500000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-332800000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	15800000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	468500000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1200200000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1184400000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	715900000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	867400000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1200200000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1184400000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	3140400000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1046900000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-17500000	USD
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	160500000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	81300000	USD
CY2019	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	263300000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	4148300000	USD
CY2020Q2	ew	Stockholders Equity Note Stock Split Number Of Newly Issued Shares Per Holder StockholdersEquityNoteStockSplitNumberOfNewlyIssuedSharesPerHolder	2	shares
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	823400000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-5100000	USD
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	140500000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	92600000	USD
CY2020	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	625400000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Stock Split AdjustmentsToAdditionalPaidInCapitalStockSplit	0	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	4574300000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1503100000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3400000	USD
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	158600000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	109300000	USD
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	512800000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	5835900000	USD
CY2021	us-gaap	Nature Of Operations NatureOfOperations	DESCRIPTION OF BUSINESSEdwards Lifesciences Corporation ("Edwards Lifesciences" or the "Company") conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. Edwards Lifesciences is focused on technologies that treat structural heart disease and critically ill patients. The products and technologies provided by Edwards Lifesciences are categorized into the following main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care.
CY2020Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	3
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements of Edwards Lifesciences have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") which have been applied consistently in all material respects. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. In particular, the COVID-19 pandemic has adversely impacted, and may further adversely impact, nearly all aspects of the Company's business and markets, including its workforce and the operations of its customers, suppliers, and business partners. The full extent to which the pandemic will directly or indirectly impact the Company's business, results of operations, and financial condition, including sales, expenses, manufacturing, clinical trials, research and development costs, reserves and allowances, fair value measurements, asset impairment charges, contingent consideration obligations, and the effectiveness of the Company's hedging instruments, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the outbreak (including new and more contagious variants of COVID-19), its severity, the actions to contain the virus or address its impact, the timing, distribution, public acceptance and efficacy of vaccines and other treatments, United States and foreign government actions to respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume.</span></div>
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	10200000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	6300000	USD
CY2021	ew	Contract With Customer Liability Revenue Recognized Excluding Opening Balance ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance	7300000	USD
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	6300000	USD
CY2021	ew	Inventory Write Down Expiration Period Trigger InventoryWriteDownExpirationPeriodTrigger	P6M
CY2021	ew	Inventory Write Down Slow Moving Period Trigger InventoryWriteDownSlowMovingPeriodTrigger	P2Y
CY2021Q4	us-gaap	General And Administrative Costs In Inventory Amount Incurred GeneralAndAdministrativeCostsInInventoryAmountIncurred	77900000	USD
CY2020Q4	us-gaap	General And Administrative Costs In Inventory Amount Incurred GeneralAndAdministrativeCostsInInventoryAmountIncurred	63100000	USD
CY2019Q4	us-gaap	General And Administrative Costs In Inventory Amount Incurred GeneralAndAdministrativeCostsInInventoryAmountIncurred	56600000	USD
CY2021Q4	us-gaap	General And Administrative Costs In Inventory Amount Remaining GeneralAndAdministrativeCostsInInventoryAmountRemaining	33700000	USD
CY2020Q4	us-gaap	General And Administrative Costs In Inventory Amount Remaining GeneralAndAdministrativeCostsInInventoryAmountRemaining	30700000	USD
CY2021Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	125800000	USD
CY2020Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	130000000	USD
CY2019	us-gaap	Inventory Write Down InventoryWriteDown	73100000	USD
CY2021	us-gaap	Depreciation Depreciation	127000000	USD
CY2020	us-gaap	Depreciation Depreciation	101800000	USD
CY2019	us-gaap	Depreciation Depreciation	84700000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1503100000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	823400000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1046900000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	623300000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	622600000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	624800000	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.41
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.32
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.68
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1503100000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	823400000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1046900000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	623300000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	622600000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	624800000	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	7900000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	9300000	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	11900000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	631200000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	631900000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	636700000	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.38
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.30
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.64
CY2020	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	405400000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	109300000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	92600000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	81300000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	18900000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	15400000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	14800000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	90400000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	77200000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	66500000	USD
CY2021	us-gaap	Maximum Length Of Time Foreign Currency Cash Flow Hedge MaximumLengthOfTimeForeignCurrencyCashFlowHedge	P13M
CY2021	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	20600000	USD
CY2019	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	33400000	USD
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	132800000	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	136700000	USD
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	164300000	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	140000000.0	USD
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	429600000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	525600000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	726700000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	802300000	USD
CY2021Q4	us-gaap	Land Land	116500000	USD
CY2020Q4	us-gaap	Land Land	97600000	USD
CY2021Q4	ew	Buildings And Leasehold Improvements Gross BuildingsAndLeaseholdImprovementsGross	1010100000	USD
CY2020Q4	ew	Buildings And Leasehold Improvements Gross BuildingsAndLeaseholdImprovementsGross	881500000	USD
CY2021Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	613400000	USD
CY2020Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	564900000	USD
CY2021Q4	ew	Equipment With Customers EquipmentWithCustomers	39200000	USD
CY2020Q4	ew	Equipment With Customers EquipmentWithCustomers	42200000	USD
CY2021Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	88200000	USD
CY2020Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	94200000	USD
CY2020Q4	ew	Accrued Litigation And Insurance Reserves AccruedLitigationAndInsuranceReserves	60800000	USD
CY2021Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	333800000	USD
CY2020Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	313300000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2201200000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1993700000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	654600000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	598500000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1546600000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1395200000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	319700000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	236700000	USD
CY2021Q4	ew	Accrued Rebates AccruedRebates	77000000.0	USD
CY2020Q4	ew	Accrued Rebates AccruedRebates	67200000	USD
CY2021Q4	ew	Accrual For Property Payroll And Other Taxes Other Than Income Taxes Current AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent	68900000	USD
CY2020Q4	ew	Accrual For Property Payroll And Other Taxes Other Than Income Taxes Current AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent	49700000	USD
CY2021Q4	ew	Research And Development Accruals ResearchAndDevelopmentAccruals	58200000	USD
CY2020Q4	ew	Research And Development Accruals ResearchAndDevelopmentAccruals	52300000	USD
CY2021Q4	ew	Accrued Litigation And Insurance Reserves AccruedLitigationAndInsuranceReserves	79100000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	30600000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	18600000	USD
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3900000	USD
CY2020Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	39300000	USD
CY2021Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	20100000	USD
CY2020Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	14300000	USD
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	11900000	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	7600000	USD
CY2021Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	19100000	USD
CY2020Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	14500000	USD
CY2021Q4	ew	Accrued Relocation Costs Current AccruedRelocationCostsCurrent	26200000	USD
CY2020Q4	ew	Accrued Relocation Costs Current AccruedRelocationCostsCurrent	21000000.0	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	87600000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	88200000	USD
CY2021Q4	ew	Accrued And Other Liabilities Current AccruedAndOtherLiabilitiesCurrent	802300000	USD
CY2020Q4	ew	Accrued And Other Liabilities Current AccruedAndOtherLiabilitiesCurrent	670200000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	20200000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	19900000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	19900000	USD
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	182500000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	197900000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	61500000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	31900000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	29700000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	28600000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	28700000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	39700000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	49600000	USD
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	54300000	USD
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	80400000	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	50800000	USD
CY2021	ew	Notes Receivable Converted To Equity Investment NotesReceivableConvertedToEquityInvestment	21500000	USD
CY2020	ew	Notes Receivable Converted To Equity Investment NotesReceivableConvertedToEquityInvestment	4500000	USD
CY2019	ew	Notes Receivable Converted To Equity Investment NotesReceivableConvertedToEquityInvestment	0	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	862800000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1183200000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1179100000	USD
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1500000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	30500000	USD
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	29700000	USD
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	16600000	USD
CY2019Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1600000	USD
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	3100000	USD
CY2020Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	400000	USD
CY2019Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	3700000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	867400000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1200200000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1184400000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	27900000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	92100000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	94200000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	25500000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	27200000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	69100000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	72700000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	94600000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	99900000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	27500000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	23000000.0	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	13600000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	8300000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	7500000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	24600000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	104500000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	9900000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	94600000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y2M12D
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y7M6D
CY2021Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.025
CY2020Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.027
CY2021	ew	Lessee Operating Lease Lease Not Yet Commenced Amount LesseeOperatingLeaseLeaseNotYetCommencedAmount	2500000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	2192700000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2900000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	11900000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	2183700000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	924300000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	11600000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	935900000	USD
CY2021Q4	us-gaap	Heldtomaturity Securities Debt Maturities Next Rolling Twelve Months Amortized Cost HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost	162000000.0	USD
CY2021Q4	us-gaap	Held To Maturity Securities Debt Maturities Next Rolling Twelve Months Fair Value HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	162000000.0	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis	441300000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	442000000.0	USD
CY2021Q4	us-gaap	Heldtomaturity Securities Debt Maturities Rolling Year Two Through Five Amortized Cost HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost	0	USD
CY2021Q4	us-gaap	Held To Maturity Securities Debt Maturities Rolling Year Two Through Five Fair Value HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	0	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis	1196700000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	1189600000	USD
CY2021Q4	us-gaap	Heldtomaturity Securities Debt Maturities Rolling Year Six Through Ten Amortized Cost HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost	0	USD
CY2021Q4	us-gaap	Held To Maturity Securities Debt Maturities Rolling Year Six Through Ten Fair Value HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue	0	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis	8700000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue	8600000	USD
CY2021Q4	us-gaap	Held To Maturity Securities Debt Maturities Without Single Maturity Date Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount	0	USD
CY2021Q4	us-gaap	Held To Maturity Securities Debt Maturities Without Single Maturity Date Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	0	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	546000000.0	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	543500000	USD
CY2021Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	162000000.0	USD
CY2021Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	162000000.0	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	2192700000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	2183700000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	1632500000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	11900000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	1632500000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	11900000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	0	investment
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	8400000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	5700000	USD
CY2021Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	84100000	USD
CY2020Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	29400000	USD
CY2021Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	92500000	USD
CY2020Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	35100000	USD
CY2021	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount	4200000	USD
CY2020	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount	1800000	USD
CY2020	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	-700000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	1167700000	USD
CY2020	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	5500000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	1173200000	USD
CY2021	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-5300000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	1167900000	USD
CY2021	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P12Y7M6D
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	352000000.0	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	246500000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	105500000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	353900000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	240600000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	113300000	USD
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	570100000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	246500000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	323600000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	572000000.0	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	240600000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	331400000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7700000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5400000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4600000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	6800000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	8400000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	8400000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	10200000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	15900000	USD
CY2021Q4	us-gaap	Longterm Debt Weighted Average Interest Rate LongtermDebtWeightedAverageInterestRate	0.034
CY2020Q4	us-gaap	Longterm Debt Weighted Average Interest Rate LongtermDebtWeightedAverageInterestRate	0.035
CY2019Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	172500000	USD
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-13600000	USD
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	186100000	USD
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	14000000.0	USD
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	124100000	USD
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	76000000.0	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1248900000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1493700000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	12700000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1080600000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1228400000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	11500000	USD
CY2021	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	7800000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths	5400000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Four DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour	5200000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Five DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive	6100000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter	36100000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Employer Contributions Next Fiscal Year DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear	2200000	USD
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	38600000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Two DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo	6700000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Three DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree	5600000	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	36600000	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	31400000	USD
CY2020Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	3
CY2021Q4	ew	Share Based Compensation Arrangement By Share Based Payment Award Intrinsic Value Of Stock Options Exercised And Vested Restricted Stock Units ShareBasedCompensationArrangementByShareBasedPaymentAwardIntrinsicValueOfStockOptionsExercisedAndVestedRestrictedStockUnits	359800000	USD
CY2020Q4	ew	Share Based Compensation Arrangement By Share Based Payment Award Intrinsic Value Of Stock Options Exercised And Vested Restricted Stock Units ShareBasedCompensationArrangementByShareBasedPaymentAwardIntrinsicValueOfStockOptionsExercisedAndVestedRestrictedStockUnits	323500000	USD
CY2019Q4	ew	Share Based Compensation Arrangement By Share Based Payment Award Intrinsic Value Of Stock Options Exercised And Vested Restricted Stock Units ShareBasedCompensationArrangementByShareBasedPaymentAwardIntrinsicValueOfStockOptionsExercisedAndVestedRestrictedStockUnits	382100000	USD
CY2021	ew	Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGrantDateFairValue	36200000	USD
CY2020	ew	Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options And Vesting Of Restricted Stock Units EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndVestingOfRestrictedStockUnits	72100000	USD
CY2019	ew	Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options And Vesting Of Restricted Stock Units EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndVestingOfRestrictedStockUnits	85100000	USD
CY2020	ew	Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGrantDateFairValue	34000000	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	82200000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	79200000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	110400000	USD
CY2021	ew	Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options And Vesting Of Restricted Stock Units EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndVestingOfRestrictedStockUnits	76500000	USD
CY2019	ew	Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGrantDateFairValue	31200000	USD
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	162300000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P30M
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	5000000.0	USD
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	12300000	USD
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	5900000	USD
CY2021	ew	Gain Loss On Investments Other Income Expense Net GainLossOnInvestmentsOtherIncomeExpenseNet	5800000	USD
CY2020	ew	Gain Loss On Investments Other Income Expense Net GainLossOnInvestmentsOtherIncomeExpenseNet	600000	USD
CY2019	ew	Gain Loss On Investments Other Income Expense Net GainLossOnInvestmentsOtherIncomeExpenseNet	500000	USD
CY2021	us-gaap	Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent	300000	USD
CY2020	us-gaap	Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent	400000	USD
CY2019	us-gaap	Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent	200000	USD
CY2021	ew	Other Income Expense Items OtherIncomeExpenseItems	2200000	USD
CY2020	ew	Other Income Expense Items OtherIncomeExpenseItems	-1000000.0	USD
CY2019	ew	Other Income Expense Items OtherIncomeExpenseItems	2000000.0	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	12700000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	11500000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8200000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	610900000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	151300000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	383400000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1091100000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	765400000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	783100000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1702000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	916700000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1166500000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	125200000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	23400000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	31300000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	25100000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	48200000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	48700000	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	92600000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	73900000	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	29100000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	242900000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	145500000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	109100000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-9400000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	11000000.0	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	28300000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-25400000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-32900000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-18300000	USD
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-9200000	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-30300000	USD
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	500000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-44000000.0	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-52200000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	10500000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	198900000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	93300000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	119600000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	109800000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	88600000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	33900000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	27000000.0	USD
CY2021Q4	ew	Deferred Tax Assets Operating Loss Carryforwards Net Of Reduction DeferredTaxAssetsOperatingLossCarryforwardsNetOfReduction	69400000	USD
CY2020Q4	ew	Deferred Tax Assets Operating Loss Carryforwards Net Of Reduction DeferredTaxAssetsOperatingLossCarryforwardsNetOfReduction	64100000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	181000000.0	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	169000000.0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	142000000.0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	125500000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	108000000.0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	105000000.0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	13500000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	16300000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Hedging Transactions DeferredTaxAssetsHedgingTransactions	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Hedging Transactions DeferredTaxAssetsHedgingTransactions	3300000	USD
CY2021Q4	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	400000	USD
CY2020Q4	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	500000	USD
CY2021Q4	ew	Deferred Tax Assets Investments In Unconsolidated Affiliates DeferredTaxAssetsInvestmentsInUnconsolidatedAffiliates	700000	USD
CY2020Q4	ew	Deferred Tax Assets Investments In Unconsolidated Affiliates DeferredTaxAssetsInvestmentsInUnconsolidatedAffiliates	1800000	USD
CY2021Q4	ew	Deferred Tax Assets Lease Liability Obligations DeferredTaxAssetsLeaseLiabilityObligations	6600000	USD
CY2020Q4	ew	Deferred Tax Assets Lease Liability Obligations DeferredTaxAssetsLeaseLiabilityObligations	7700000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	82500000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1300000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3600000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	485600000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	443400000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	64100000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	53400000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	6400000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	0	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	26300000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	29200000	USD
CY2021Q4	ew	Deferred Tax Liability Operating Lease Right Of Use Amortization DeferredTaxLiabilityOperatingLeaseRightOfUseAmortization	6100000	USD
CY2020Q4	ew	Deferred Tax Liability Operating Lease Right Of Use Amortization DeferredTaxLiabilityOperatingLeaseRightOfUseAmortization	7000000.0	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	75500000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	76300000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2600000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	3100000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	71600000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	222100000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	202800000	USD
CY2021	ew	Increase Decrease In Deferred Tax Assets Liabilities Net IncreaseDecreaseInDeferredTaxAssetsLiabilitiesNet	19300000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	82500000	USD
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	456600000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	69600000	USD
CY2021Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	53900000	USD
CY2021Q4	ew	Deferred Tax Assets Operating Loss Carryforwards Net Of Valuation Allowance DeferredTaxAssetsOperatingLossCarryforwardsNetOfValuationAllowance	15700000	USD
CY2021Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	194800000	USD
CY2021Q4	us-gaap	Tax Credit Carryforward Valuation Allowance TaxCreditCarryforwardValuationAllowance	26300000	USD
CY2021Q4	ew	Tax Credit Carryforward Deferred Tax Asset Net Of Valuation Allowance TaxCreditCarryforwardDeferredTaxAssetNetOfValuationAllowance	168500000	USD
CY2021Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	1000000000	USD
CY2021	ew	Foreign Earnings To Be Repatriated ForeignEarningsToBeRepatriated	392900000	USD
CY2021Q4	us-gaap	Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Foreign Subsidiaries DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries	23100000	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	357400000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	192500000	USD
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	245000000.0	USD
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-122200000	USD
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-80500000	USD
CY2019	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-75000000.0	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	11900000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	5000000.0	USD
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	11900000	USD
CY2021	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	48400000	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	43100000	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	42900000	USD
CY2021	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	3600000	USD
CY2020	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	4200000	USD
CY2019	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	5000000.0	USD
CY2021	ew	Effective Income Tax Rate Reconciliation Tax On Global Intangible Low Taxed Income Amount EffectiveIncomeTaxRateReconciliationTaxOnGlobalIntangibleLowTaxedIncomeAmount	56500000	USD
CY2020	ew	Effective Income Tax Rate Reconciliation Tax On Global Intangible Low Taxed Income Amount EffectiveIncomeTaxRateReconciliationTaxOnGlobalIntangibleLowTaxedIncomeAmount	49200000	USD
CY2019	ew	Effective Income Tax Rate Reconciliation Tax On Global Intangible Low Taxed Income Amount EffectiveIncomeTaxRateReconciliationTaxOnGlobalIntangibleLowTaxedIncomeAmount	32000000.0	USD
CY2021	us-gaap	Income Tax Reconciliation Deductions IncomeTaxReconciliationDeductions	1300000	USD
CY2020	us-gaap	Income Tax Reconciliation Deductions IncomeTaxReconciliationDeductions	2600000	USD
CY2019	us-gaap	Income Tax Reconciliation Deductions IncomeTaxReconciliationDeductions	7200000	USD
CY2021	ew	Effective Income Tax Rate Reconciliation Contingent Consideration Liability EffectiveIncomeTaxRateReconciliationContingentConsiderationLiability	26100000	USD
CY2020	ew	Effective Income Tax Rate Reconciliation Contingent Consideration Liability EffectiveIncomeTaxRateReconciliationContingentConsiderationLiability	-2900000	USD
CY2019	ew	Effective Income Tax Rate Reconciliation Contingent Consideration Liability EffectiveIncomeTaxRateReconciliationContingentConsiderationLiability	1300000	USD
CY2021	ew	Effective Income Tax Rate Reconciliation Deduction Sharebased Compensation Cost Amount EffectiveIncomeTaxRateReconciliationDeductionSharebasedCompensationCostAmount	47800000	USD
CY2020	ew	Effective Income Tax Rate Reconciliation Deduction Sharebased Compensation Cost Amount EffectiveIncomeTaxRateReconciliationDeductionSharebasedCompensationCostAmount	48300000	USD
CY2019	ew	Effective Income Tax Rate Reconciliation Deduction Sharebased Compensation Cost Amount EffectiveIncomeTaxRateReconciliationDeductionSharebasedCompensationCostAmount	57600000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	5300000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	4200000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	3200000	USD
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	10000000.0	USD
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	9800000	USD
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	6500000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	198900000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	93300000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	119600000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	358400000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	281800000	USD
CY2021Q4	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	135100000	USD
CY2020Q4	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	95100000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	223300000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	186700000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	3700000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	281800000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	203100000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	150700000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	82100000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	86400000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	55400000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	2300000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	6000000.0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	800000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	4800000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	10000000.0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	3800000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	300000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	2700000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	358400000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	281800000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	203100000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	19500000	USD
CY2021Q4	ew	Unrecognized Tax Benefits Accrued Interest Tax Benefit UnrecognizedTaxBenefitsAccruedInterestTaxBenefit	8100000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	14300000	USD
CY2020Q4	ew	Unrecognized Tax Benefits Accrued Interest Tax Benefit UnrecognizedTaxBenefitsAccruedInterestTaxBenefit	5100000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	5200000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	5000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	4700000	USD
CY2021	us-gaap	Income Tax Examination Estimate Of Possible Loss IncomeTaxExaminationEstimateOfPossibleLoss	180000000	USD
CY2021	ew	Loss Contingency Claims That If Settled Could Have A Material Adverse Impact Number LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber	1	lawsuit
CY2021Q4	ew	Accrual For Environmental Loss Contingencies Threshold Amount For Disclosure AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure	1000000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5232500000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4386300000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4348000000	USD
CY2019	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	64600000	USD
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-124100000	USD
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	13600000	USD
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-6100000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	1690300000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	897600000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	1146800000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1702000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	916700000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1166500000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5232500000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4386300000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4348000000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5232500000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4386300000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4348000000	USD
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	1748900000	USD
CY2020Q4	us-gaap	Noncurrent Assets NoncurrentAssets	1608400000	USD
CY2019Q4	us-gaap	Noncurrent Assets NoncurrentAssets	1241700000	USD

Files In Submission

Name	View Source	Status
0001099800-22-000005-index-headers.html	Edgar Link	pending
0001099800-22-000005-index.html	Edgar Link	pending
0001099800-22-000005.txt	Edgar Link	pending
0001099800-22-000005-xbrl.zip	Edgar Link	pending
ew-20211231.htm	Edgar Link	pending
ew-20211231.xsd	Edgar Link	pending
ew-20211231_cal.xml	Edgar Link	unprocessable
ew-20211231_def.xml	Edgar Link	unprocessable
ew-20211231_g1.jpg	Edgar Link	pending
ew-20211231_g10.jpg	Edgar Link	pending
ew-20211231_g11.jpg	Edgar Link	pending
ew-20211231_g12.jpg	Edgar Link	pending
ew-20211231_g13.jpg	Edgar Link	pending
ew-20211231_g2.jpg	Edgar Link	pending
ew-20211231_g3.jpg	Edgar Link	pending
ew-20211231_g4.jpg	Edgar Link	pending
ew-20211231_g5.jpg	Edgar Link	pending
ew-20211231_g6.jpg	Edgar Link	pending
ew-20211231_g7.jpg	Edgar Link	pending
ew-20211231_g8.jpg	Edgar Link	pending
ew-20211231_g9.jpg	Edgar Link	pending
ew-20211231_htm.xml	Edgar Link	completed
ew-20211231_lab.xml	Edgar Link	unprocessable
ew-20211231_pre.xml	Edgar Link	unprocessable
ex-101110xkq42021.htm	Edgar Link	pending
ex-101210xkq42021.htm	Edgar Link	pending
ex-101310xkq42021.htm	Edgar Link	pending
ex-101510xkq42021.htm	Edgar Link	pending
ex-101610xkq42021.htm	Edgar Link	pending
ex-101710xkq42021.htm	Edgar Link	pending
ex-101810xkq42021.htm	Edgar Link	pending
ex-21110xkq42021.htm	Edgar Link	pending
ex-2310xkq42021.htm	Edgar Link	pending
ex-31110xkq42021.htm	Edgar Link	pending
ex-31210xkq42021.htm	Edgar Link	pending
ex-3210xkq42021.htm	Edgar Link	pending
ex-4210xkq42021.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_0.jpg	Edgar Link	pending
image_1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EW
Edwards Lifesciences Corp Stock $ew

2021 Form 10-K Financial Statement

#000109980022000005 Filed on February 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EW Edwards Lifesciences Corp Stock $ew

2021 Form 10-K Financial Statement

#000109980022000005 Filed on February 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EW
Edwards Lifesciences Corp Stock $ew